Cargando…
PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428714/ http://dx.doi.org/10.1097/01.HS9.0000975036.56231.93 |
| _version_ | 1785090535317307392 |
|---|---|
| author | Kulasekararaj, Austin Lanza, Francesco Arvanitakis, Alexandros Langemeijer, Saskia Chonat, Satheesh Cao, Jia Chow, Vincent Henary, Haby |
| author_facet | Kulasekararaj, Austin Lanza, Francesco Arvanitakis, Alexandros Langemeijer, Saskia Chonat, Satheesh Cao, Jia Chow, Vincent Henary, Haby |
| author_sort | Kulasekararaj, Austin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428714 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104287142023-08-17 PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) Kulasekararaj, Austin Lanza, Francesco Arvanitakis, Alexandros Langemeijer, Saskia Chonat, Satheesh Cao, Jia Chow, Vincent Henary, Haby Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428714/ http://dx.doi.org/10.1097/01.HS9.0000975036.56231.93 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Kulasekararaj, Austin Lanza, Francesco Arvanitakis, Alexandros Langemeijer, Saskia Chonat, Satheesh Cao, Jia Chow, Vincent Henary, Haby PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |
| title | PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |
| title_full | PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |
| title_fullStr | PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |
| title_full_unstemmed | PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |
| title_short | PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |
| title_sort | pb2059: sensitivity and subgroup analyses further support clinical similarity in efficacy between abp 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria (pnh) |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428714/ http://dx.doi.org/10.1097/01.HS9.0000975036.56231.93 |
| work_keys_str_mv | AT kulasekararajaustin pb2059sensitivityandsubgroupanalysesfurthersupportclinicalsimilarityinefficacybetweenabp959andeculizumabreferenceproductinpatientswithparoxysmalnocturnalhemoglobinuriapnh AT lanzafrancesco pb2059sensitivityandsubgroupanalysesfurthersupportclinicalsimilarityinefficacybetweenabp959andeculizumabreferenceproductinpatientswithparoxysmalnocturnalhemoglobinuriapnh AT arvanitakisalexandros pb2059sensitivityandsubgroupanalysesfurthersupportclinicalsimilarityinefficacybetweenabp959andeculizumabreferenceproductinpatientswithparoxysmalnocturnalhemoglobinuriapnh AT langemeijersaskia pb2059sensitivityandsubgroupanalysesfurthersupportclinicalsimilarityinefficacybetweenabp959andeculizumabreferenceproductinpatientswithparoxysmalnocturnalhemoglobinuriapnh AT chonatsatheesh pb2059sensitivityandsubgroupanalysesfurthersupportclinicalsimilarityinefficacybetweenabp959andeculizumabreferenceproductinpatientswithparoxysmalnocturnalhemoglobinuriapnh AT caojia pb2059sensitivityandsubgroupanalysesfurthersupportclinicalsimilarityinefficacybetweenabp959andeculizumabreferenceproductinpatientswithparoxysmalnocturnalhemoglobinuriapnh AT chowvincent pb2059sensitivityandsubgroupanalysesfurthersupportclinicalsimilarityinefficacybetweenabp959andeculizumabreferenceproductinpatientswithparoxysmalnocturnalhemoglobinuriapnh AT henaryhaby pb2059sensitivityandsubgroupanalysesfurthersupportclinicalsimilarityinefficacybetweenabp959andeculizumabreferenceproductinpatientswithparoxysmalnocturnalhemoglobinuriapnh |